Humanized Mouse Models for the p53 R72P SNP

p53 R72P SNP 人源化小鼠模型

基本信息

  • 批准号:
    8391757
  • 负责人:
  • 金额:
    $ 28.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-12-01 至 2014-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Individuals exposed to the same environmental agent often respond differently due to additional factors such as genetics. Therefore, determining how human sequence variations (polymorphisms) influence the response to environmental exposures is key to understanding individual variability in disease susceptibility. The human p53 gene, which plays a critical role in the response to many cellular stresses, contains a common polymorphism that results in either an arginine (R) or proline (P) residue at position 72 of the p53 protein. Numerous epidemiological studies have associated this polymorphism with risk for developing various cancers and other diseases. However, different genotypes are associated with a predisposition for developing different cancers and in some cases there is conflicting data. Some laboratory studies suggest that the two p53 variants differ in their abilities to activate certain target genes while other studies suggest that the variants differ in their ability to induce apoptosis through a transcription-independent mechanism. Moreover, this polymorphism may affect the gain-of-function ability of mutant p53. A major problem with the interpretation of these functional studies is that all were done using artificial in vitro conditions and thus there is a critical need to model the R72P polymorphism in a way that is more physiologically relevant. This application is based on the hypothesis that the human p53 R72P polymorphism can be modeled in the mouse and that these models can be important tools for basic and translational research. Mouse models have been developed to study the role of specific mutations and sites of modification on p53, but no mouse model has been developed to study the R72P polymorphism. This may be because amino acid 72 is located in a region of human p53 that lacks homology to murine p53. To overcome this problem, we have used two different approaches to develop "humanized" mouse models for the p53 R72P polymorphism. Experiments proposed in this application will validate these mouse models with a focus on determining how the R72P polymorphism modulates apoptosis and skin cancer development. The long-term objective of this proposal is to use data from these mouse model studies to develop and test new hypothesis on the role of this p53 polymorphism in human health and disease.
描述(由申请人提供):由于遗传等其他因素,暴露于相同环境因子的个体往往反应不同。因此,确定人类序列变异(多态性)如何影响对环境暴露的反应是理解疾病易感性个体差异的关键。人p53基因在对许多细胞应激的反应中起关键作用,其含有常见的多态性,该多态性导致p53蛋白的第72位的精氨酸(R)或脯氨酸(P)残基。许多流行病学研究已经将这种多态性与发展各种癌症和其他疾病的风险相关联。然而,不同的基因型与发展不同癌症的倾向有关,在某些情况下,存在相互矛盾的数据。一些实验室研究表明,这两种p53变体在激活某些靶基因的能力上不同,而其他研究表明,这两种变体在通过转录非依赖性机制诱导细胞凋亡的能力上不同。此外,这种多态性可能会影响突变型p53的功能获得能力。解释这些功能性研究的一个主要问题是,所有这些都是使用人工体外条件进行的,因此迫切需要以更生理相关的方式对R72P多态性进行建模。该应用基于这样的假设,即人p53 R72P多态性可以在小鼠中建模,并且这些模型可以是基础和转化研究的重要工具。已经开发了小鼠模型来研究p53上的特定突变和修饰位点的作用,但是还没有开发小鼠模型来研究R72P多态性。这可能是因为氨基酸72位于与鼠p53缺乏同源性的人p53的区域中。为了克服这个问题,我们使用了两种不同的方法来开发p53 R72P多态性的“人源化”小鼠模型。本申请中提出的实验将验证这些小鼠模型,重点是确定R72P多态性如何调节细胞凋亡和皮肤癌的发展。该提案的长期目标是使用这些小鼠模型研究的数据来开发和测试关于这种p53多态性在人类健康和疾病中的作用的新假设。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David G. Johnson其他文献

Charged behaviour from neutral ligands: synthesis and properties of N-heterocyclic pseudo-amides.
中性配体的带电行为:N-杂环假酰胺的合成和性质。
  • DOI:
    10.1002/chem.201103319
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. Thatcher;David G. Johnson;John M. Slattery;R. Douthwaite
  • 通讯作者:
    R. Douthwaite
Wellbeing in policy analysis
政策分析中的福祉
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Phillip H. Smith;Frederick W. Merchant;David G. Johnson;W. Fujimoto;Robert H. Williams
  • 通讯作者:
    Robert H. Williams
Observations of downwelling far-infrared emission at Table Mountain California made by the FIRST instrument
FIRST 仪器对加利福尼亚州桌山下流远红外发射的观测
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Mlynczak;R. Cageao;J. Mast;D. Kratz;H. Latvakoski;David G. Johnson
  • 通讯作者:
    David G. Johnson
Spectacle and Sacrifice: The Ritual Foundations of Village Life in North China
  • DOI:
    10.2307/j.ctt1x07vxp
  • 发表时间:
    2010-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David G. Johnson
  • 通讯作者:
    David G. Johnson
Stratospheric age spectra derived from observations of water vapor and methane
来自水蒸气和甲烷观测的平流层年龄光谱
  • DOI:
    10.1029/1999jd900363
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David G. Johnson;K. Jucks;W. Traub;K. Chance;G. Toon;J. Russell;M. McCormick
  • 通讯作者:
    M. McCormick

David G. Johnson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David G. Johnson', 18)}}的其他基金

The E2F1 Post-Translational Modification Code
E2F1 翻译后修饰代码
  • 批准号:
    10440288
  • 财政年份:
    2018
  • 资助金额:
    $ 28.39万
  • 项目类别:
The E2F1 Post-Translational Modification Code
E2F1 翻译后修饰代码
  • 批准号:
    10218068
  • 财政年份:
    2018
  • 资助金额:
    $ 28.39万
  • 项目类别:
MD Anderson Science Park Summer Program in Cancer Research SPCR
MD 安德森科学园癌症研究 SPCR 暑期项目
  • 批准号:
    8910669
  • 财政年份:
    2014
  • 资助金额:
    $ 28.39万
  • 项目类别:
MD Anderson Science Park Summer Program in Cancer Research SPCR
MD 安德森科学园癌症研究 SPCR 暑期项目
  • 批准号:
    9788953
  • 财政年份:
    2014
  • 资助金额:
    $ 28.39万
  • 项目类别:
MD Anderson Science Park Summer Program in Cancer Research SPCR
MD 安德森科学园癌症研究 SPCR 暑期项目
  • 批准号:
    10017162
  • 财政年份:
    2014
  • 资助金额:
    $ 28.39万
  • 项目类别:
MD Anderson Science Park Summer Program in Cancer Research SPCR
MD 安德森科技园癌症研究 SPCR 暑期项目
  • 批准号:
    8739963
  • 财政年份:
    2014
  • 资助金额:
    $ 28.39万
  • 项目类别:
MD Anderson Science Park Summer Program in Cancer Research SPCR
MD 安德森科学园癌症研究 SPCR 暑期项目
  • 批准号:
    9323335
  • 财政年份:
    2014
  • 资助金额:
    $ 28.39万
  • 项目类别:
Humanized Mouse Models for the p53 R72P SNP
p53 R72P SNP 人源化小鼠模型
  • 批准号:
    7812646
  • 财政年份:
    2009
  • 资助金额:
    $ 28.39万
  • 项目类别:
Humanized Mouse Models for the p53 R72P SNP
p53 R72P SNP 人源化小鼠模型
  • 批准号:
    7996051
  • 财政年份:
    2008
  • 资助金额:
    $ 28.39万
  • 项目类别:
Humanized Mouse Models for the p53 R72P SNP
p53 R72P SNP 人源化小鼠模型
  • 批准号:
    8207922
  • 财政年份:
    2008
  • 资助金额:
    $ 28.39万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 28.39万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 28.39万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 28.39万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 28.39万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 28.39万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 28.39万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 28.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 28.39万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 28.39万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 28.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了